Deepu Varughese

University of California, Los Angeles

Papers

1

Total Citations

4

H-Index

1

About

Dr. Deepu Varughese is a leading clinician-researcher in urologic oncology, with a specialized focus on prostate cancer recurrence and advanced surgical interventions. His major contributions center on the clinical application of prostate-specific membrane antigen (PSMA) radioguided surgery, particularly for salvage lymph node dissection in patients with biochemical recurrence after initial treatment. In his landmark prospective exploratory trial, Dr. Varughese demonstrated the feasibility and short-term clinical responses of PSMA-targeted salvage pelvic lymphadenectomy, providing critical evidence for a targeted, image-guided approach to managing recurrent prostate cancer. This work, already garnering early citations, has helped refine surgical strategies for patients with limited nodal relapse, offering a potential pathway to delay systemic therapy. Beyond this, his research integrates molecular imaging with precision surgery, bridging the gap between diagnostic advances and therapeutic outcomes. Dr. Varughese’s contributions are shaping how clinicians approach oligometastatic prostate cancer, and his ongoing work continues to influence guidelines for salvage treatment, making him a key voice in the evolving landscape of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Clinical Responses to Prostate-specific Membrane Antigen Radioguided Salvage Lymphadenectomy for Prostate Cancer Recurrence: Results from a Prospective Exploratory Trial
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of California, Los Angeles

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago